Yale spin-off company Modifi Bio acquired by Merck in multimillion dollar deal

Modifi Bio’s founders discuss the journey from developing a cancer treatment drug to being acquired by Big Pharma.

At Yale School of Medicine, students learn without grades

The News reached out to faculty and students at the Yale School of Medicine to gauge views on The Yale System of Medical Education’s pass/fail approach.